Content |
Biography
2010-2019
Nikolai Kapustin's career at Fresenius Medical Care began in 2010. At first he was in the position of analyst, at various times he worked as a sales manager in Russia, Kazakhstan and EEMEA (Eastern Europe, Russia, Middle East and Africa). In December 2019, he became Sales Director of Fresenius Medical Care in Russia and the CIS countries .
2023: Appointment as CEO
At the end of January 2023, it became known about the change of the general director of the Russian representative office of Fresenius Medical Care. Instead of Alexei Myagkov, who led the company since 2005, Nikolai Kapustin was appointed. This is evidenced by the data of the SPARK-Interfax system.
After more than 30 years of work in the company, the general director of Fresenius SP JSC Alexei Myagkov decided to retire, the press service of Fresenius SP JSC reported. |
Nikolai Kapustin took the post of general director and head of commercial operations of Fresenius Medical Care in Russia from January 1, 2023. Changes to the Unified State Register of Legal Entities on the change of the general director of Russian business - Fresenius SP JSC - were made on January 26, 2023. A week earlier, Nikolai Kapustin headed another company that is part of the perimeter of the Fresenius Medical Care group in Russia, Fresenius Medical Kea Holding LLC.
Fresenius Medical Care acts as a solution delivery operator for patients with kidney disease. Through its network of 4,153 dialysis clinics, Fresenius Medical Care provides dialysis procedures for approximately 345,000 patients worldwide, and 3.8 million patients receive total medical services using the company's solutions.
As of January 2023, Fresenius Medical Care operates 96 dialysis centers in 36 regions of Russia, in which more than 8 thousand patients undergo procedures (the largest operators of dialysis centers are Fresenius Nefrokea LLC and Dialysis Center LLC). The company also acts as a vendor of equipment and consumables for hemodialysis, more than 300 clinics in Russia act as clients of the company.